Advances in the study of tertiary lymphoid structures in the immunotherapy of breast cancer.

Abstract

Breast cancer, as one of the most common malignancies in women, exhibits complex and heterogeneous pathological characteristics across different subtypes. Triple-negative breast cancer (TNBC) and HER2-positive breast cancer are two common and highly invasive subtypes within breast cancer. The stability of the breast microbiota is closely intertwined with the immune environment, and immunotherapy is a common approach for treating breast cancer.Tertiary lymphoid structures (TLSs), recently discovered immune cell aggregates surrounding breast cancer, resemble secondary lymphoid organs (SLOs) and are associated with the prognosis and survival of some breast cancer patients, offering new avenues for immunotherapy. Machine learning, as a form of artificial intelligence, has increasingly been used for detecting biomarkers and constructing tumor prognosis models. This article systematically reviews the latest research progress on TLSs in breast cancer and the application of machine learning in the detection of TLSs and the study of breast cancer prognosis. The insights provided contribute valuable perspectives for further exploring the biological differences among different subtypes of breast cancer and formulating personalized treatment strategies.

• Authors: Xin Li, Han Xu, Ziwei Du, Qiang Cao, Xiaofei Liu
• Journal: Frontiers in oncology (Front Oncol) Vol. 14 Pg. 1382701 ( 2024) ISSN: 2234-943X [Print] Switzerland
• PMID: 38628669 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2024 Li, Xu, Du, Cao and Liu.